Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Ownership of uncertainty: healthcare professionals counseling and treating women from hereditary breast and ovarian cancer families who receive an inconclusive BRCA1/2 genetic test result.

Kenen R, Ardern-Jones A, Lynch E, Eeles R.

Genet Test Mol Biomarkers. 2011 Apr;15(4):243-50. doi: 10.1089/gtmb.2010.0071. Epub 2011 Jan 22.

2.

[Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].

Leblond D, Brédart A, Dolbeault S, De Pauw A, Stoppa Lyonnet D, Flahault C, Sultan S.

Bull Cancer. 2011 Feb;98(2):184-98. doi: 10.1684/bdc.2011.1309. Review. French.

3.

Counseling the at risk patient in the BRCA1 and BRCA2 Era.

Barnes-Kedar IM, Plon SE.

Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. Review.

PMID:
12108833
4.
5.

Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.

Forman AD, Hall MJ.

Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Review.

PMID:
19775331
6.

Psychosocial aspects of genetic counseling and testing.

Vadaparampil ST, Wey JP, Kinney AY.

Semin Oncol Nurs. 2004 Aug;20(3):186-95. Review.

PMID:
15491028
7.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
8.

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Pruthi S, Gostout BS, Lindor NM.

Mayo Clin Proc. 2010 Dec;85(12):1111-20. doi: 10.4065/mcp.2010.0414. Review.

9.

Psychosocial and behavioral impact of genetic counseling and testing.

Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB.

Breast Dis. 2006-2007;27:97-108. Review.

PMID:
17917142
10.

Hereditary Breast and ovarian cancer: providing personalized medicine.

Tranin AS.

AWHONN Lifelines. 2005 Oct-Nov;9(5):372-6. Review. No abstract available.

PMID:
16359075
11.

Familial breast and ovarian cancers.

Arai M, Utsunomiya J, Miki Y.

Int J Clin Oncol. 2004 Aug;9(4):270-82. Review.

PMID:
15375703
12.

Genetic counselling for hereditary predisposition to ovarian and breast cancer.

Mackay J, Szecsei CM.

Ann Oncol. 2010 Oct;21 Suppl 7:vii334-8. doi: 10.1093/annonc/mdq365. Review.

PMID:
20943638
13.

The pros and cons of genetic testing for breast and ovarian cancer risk.

Frank TS, Braverman AM.

Int J Fertil Womens Med. 1999 May-Jun;44(3):139-45. Review.

PMID:
10435912
14.

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

Shulman LP.

Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Review.

PMID:
20494261
15.

Identifying and managing hereditary risk of breast and ovarian cancer.

Frank TS, Critchfield GC.

Clin Perinatol. 2001 Jun;28(2):395-406. Review.

PMID:
11499060
16.

Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.

Prucka SK, McIlvried DE, Korf BR.

Med Princ Pract. 2008;17(3):173-89. doi: 10.1159/000117790. Epub 2008 Apr 10. Review.

17.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
18.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

19.

[Psychological and familial aspects of the familial breast and ovarian cancer genetic counseling process].

Flugelman A, Rennert G, Eidelman S.

Harefuah. 2014 Jan;153(1):22-6, 65. Review. Hebrew.

PMID:
24605403
20.

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.

Khabele D, Runowicz CD.

Curr Womens Health Rep. 2002 Jun;2(3):163-9. Review.

PMID:
12099190

Supplemental Content

Support Center